Durintechnologies
1 known investors
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.
AI & Machine LearningBiotechDigital Health